Sarepta Therapeutics H-1B salaries (2026)
Yes — Sarepta Therapeutics sponsors H-1B workers. Across 20 certified Labor Condition Applications, the median offered base wage is $126,003. Every figure below comes straight from the employer's own filings with the U.S. Department of Labor.
Sarepta Therapeutics filed 20 certified H-1B labor condition applications across 1 state between Dec 2024 and Feb 2026. The median offered base wage was $126,003.
- Median offered wage
- $126,003
- Certified filings
- 20
- Work locations
- 1 states
- Distinct roles
- 18
Most-filed roles at Sarepta Therapeutics
| Role | Filings | Median wage |
|---|---|---|
| Scientist Ii, Discovery Chemistry | 2 | $121,000 |
| Associate Director, Statistical Programming | 2 | $179,000 |
| Director, Regulatory Affairs Cmc | 1 | $197,000 |
| Engineer, Rna Drug Substance Manufacturing | 1 | $85,000 |
| Executive Dir., Gene Therapy Commercialization Capabilities | 1 | $279,000 |
| Principal Engineer, Manufacturing Sciences And Technology | 1 | $148,000 |
| Principal Scientist, Analytical Development | 1 | $157,000 |
| Quality Control Associate Ii “ Physical Titer | 1 | $85,000 |
| Quality Control Associate Ii, Potency | 1 | $85,000 |
| Quality Control Investigations Manager | 1 | $126,000 |
| Scientist Ii, Drug Product Development | 1 | $126,006 |
| Senior Engineer, Gene Therapy Upstream Process Development | 1 | $104,416 |
Wage-level distribution
DOL prevailing-wage levels reflect the seniority the employer certified, from Level I (entry) to Level IV (fully competent).
| Level | Filings | Median wage |
|---|---|---|
| Level I — entry | 4 | $85,000 |
| Level II — qualified | 5 | $107,099 |
| Level III — experienced | 5 | $148,000 |
| Level IV — fully competent | 6 | $179,000 |
Where Sarepta Therapeutics hires
| State | Filings | Median wage |
|---|---|---|
| Massachusetts | 20 | $126,003 |
Recent certified filings
| Job title | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Sr. Principal Engineer, Manufacturing Sciences & Technology | Bedford, Massachusetts | $170,000 | IV | Feb 2026 |
| Director, Regulatory Affairs CMC | Cambridge, Massachusetts | $197,000 | III | Feb 2026 |
| Quality Control Investigations Manager | Andover, Massachusetts | $126,000 | I | Nov 2025 |
| Principal Engineer, Manufacturing Sciences and Technology | Bedford, Massachusetts | $148,000 | III | Jul 2025 |
| Senior Engineer, Gene Therapy Upstream Process Development | Bedford, Massachusetts | $104,416 | II | Jul 2025 |
| Engineer, RNA Drug Substance Manufacturing | Andover, Massachusetts | $85,000 | I | Jul 2025 |
| Executive Dir., Gene Therapy Commercialization Capabilities | Cambridge, Massachusetts | $279,000 | IV | Jul 2025 |
| Scientist II, Discovery Chemistry | Bedford, Massachusetts | $121,000 | II | Jun 2025 |
| Associate Director, Statistical Programming | Cambridge, Massachusetts | $179,000 | IV | Jun 2025 |
| Quality Control Associate II “ Physical Titer | Andover, Massachusetts | $85,000 | I | Jun 2025 |
| Associate Director, Statistical Programming | Cambridge, Massachusetts | $179,000 | IV | May 2025 |
| Senior Research Associate | Andover, Massachusetts | $107,099 | II | May 2025 |
| Scientist II, Discovery Chemistry | Cambridge, Massachusetts | $121,000 | II | May 2025 |
| Data Analytics Lead Engineer | Burlington, Massachusetts | $126,000 | III | Apr 2025 |
| Quality Control Associate II, Potency | Andover, Massachusetts | $85,000 | I | Apr 2025 |
| Senior Research Associate, Translational Biology | Andover, Massachusetts | $90,000 | II | Apr 2025 |
| Scientist II, Drug Product Development | Andover, Massachusetts | $126,006 | III | Apr 2025 |
| Senior Manager, Supply Chain Planning and Analytics | Burlington, Massachusetts | $148,000 | III | Mar 2025 |
| Principal Scientist, Analytical Development | Andover, Massachusetts | $157,000 | IV | Mar 2025 |
| Director, CMC Procurement | Burlington, Massachusetts | $202,000 | IV | Dec 2024 |
Source: U.S. Department of Labor OFLC certified Labor Condition Applications (H-1B, H-1B1, E-3), public disclosure data. Wages are employer-offered base pay and exclude bonuses, equity, and other compensation. Denied and withdrawn filings are excluded. Figures reflect filings decided Dec 2024–Feb 2026.
Compare across employers
For general educational purposes, not career or financial advice. Wages are employer-offered base pay from certified DOL LCA records and may differ from total compensation.